摘要
射血分数保留的心力衰竭(HFpEF)是一组常见的临床症候群。随着发病率增加,HFpEF逐渐引起了人们的关注,但目前仍无指南推荐标准治疗方案。近年来在HFpEF治疗领域取得一些新的进展,新型药物及相关器械治疗逐渐成为研究热点。
Heart failure with preserved ejection fraction(HFpEF) is a common clinical syndrome. With the increase of incidence,HFpEF has attracted more and more attention,but there is still no guideline to recommend standard treatment. In recent years,some new advances have been made in the field of HFpEF treatment. New drugs and related devices have gradually been a research hotspot.
作者
张健
张宇辉
ZHANG Jian;ZHANG Yuhui(Chinese Academy of Medical Sciences,Peking Union Medical College,National Center for Cardiovascular Diseases,Fuwai Hospital,National Key Laboratory of Cardiovascular Diseases,Heart Failure Center,Beijing 100037,China)
出处
《心血管病学进展》
CAS
2019年第2期161-165,共5页
Advances in Cardiovascular Diseases
关键词
射血分数保留的心力衰竭
治疗
Heart failure with preserved ejection fraction
Treatment
